Clinical impact of mutations in driver oncogenes and TP53/RB1 in advanced prostate cancer.

被引：0
|
作者：
Hammer, Liat
Rebernick, Ryan
McFarlane, Matthew
Westbrook, Thomas
Hazime, Munna
Hammoud, Tanya
Chiu, Pin-en
Xavier, Owens
Wu, Yi-Mi
Robinson, Dan R.
Spratt, Daniel Eidelberg
Alva, Ajjai Shivaram
Jackson, William C.
Reichert, Zachery R.
Alumkal, Joshi J.
Chinnaiyan, Arul
Cieslik, Marcin
Dess, Robert Timothy
机构：
[1] Univ Michigan, Ann Arbor, MI USA
[2] Case Western Reserve Univ, Univ Hosp Cleveland, Med Ctr, Cleveland, OH USA
[3] Univ Michigan, Div Hematol & Oncol, Dept Internal Med, Ann Arbor, MI USA
[4] Univ Michigan, Canc Ctr, Ann Arbor, MI USA
[5] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA
[6] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[7] Michigan Med, Ann Arbor, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
263
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CIGARETTE SMOKING AND TP53 GENE MUTATIONS IN BLADDER CANCER.
    Samanic, C.
    Baris, D. R.
    Silverman, D. T.
    Platz, E. A.
    Strickland, P. T.
    Schwenn, M. R.
    Schned, A. T.
    Johnson, A. R.
    Kida, M.
    Jones, M. A.
    Nickerson, M. L.
    Rothman, N.
    Moore, L. E.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S4 - S4
  • [22] Clinical Outcomes and Correlates of TP53 Mutations and Cancer
    Robles, Ana I.
    Harris, Curtis C.
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (03): : a001016
  • [23] Analysis of TP53 gain of function mutations in metastatic castration-resistant prostate cancer.
    Sweeney, Patrick L.
    Lanka, Sree M.
    Jang, Albert
    Gupta, Kanika
    Caputo, Sydney
    Casado, Crystal
    Huang, Minqi
    Pocha, Olivia
    Hawkins, Maddie
    Lieberman, Alexandra
    Schwartz, Jennifer
    Jaeger, Ellen B.
    Miller, Patrick
    Barata, Pedro C.
    Layton, Jodi Lyn
    Lewis, Brian E.
    Ledet, Elisa M.
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [24] Locally recurrent prostate cancer with RB1/TP53 alterations successfully treated by salvage focal brachytherapy: a case report
    Komori, Takahiro
    Kosaka, Takeo
    Tanaka, Tomoki
    Watanabe, Keitaro
    Yasumizu, Yota
    Mikami, Shuji
    Oya, Mototsugu
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2023, 11 (04): : 339 - 343
  • [25] Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress
    Nyquist, Michael D.
    Corella, Alexandra
    Coleman, Ilsa
    De Sarkar, Navonil
    Kaipainen, Arja
    Ha, Gavin
    Gulati, Roman
    Ang, Lisa
    Chatterjee, Payel
    Lucas, Jared
    Pritchard, Colin
    Risbridger, Gail
    Isaacs, John
    Montgomery, Bruce
    Morrissey, Colm
    Corey, Eva
    Nelson, Peter S.
    CELL REPORTS, 2020, 31 (08):
  • [26] Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer
    Zhou, Jie
    Lai, Yiming
    Peng, Shengmeng
    Tang, Chen
    Chen, Yongming
    Li, Lingfeng
    Huang, Hai
    Guo, Zhenghui
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer
    Velez, Miguel Gonzalez
    Kosiorek, Heidi E.
    Egan, Jan B.
    McNatty, Andrea L.
    Riaz, Irbaz B.
    Hwang, Steven R.
    Stewart, Glenn A.
    Ho, Thai H.
    Moore, Cassandra N.
    Singh, Parminder
    Sharpsten, Renee K.
    Costello, Brian A.
    Bryce, Alan H.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (03) : 479 - 483
  • [28] Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer
    Miguel Gonzalez Velez
    Heidi E. Kosiorek
    Jan B. Egan
    Andrea L. McNatty
    Irbaz B. Riaz
    Steven R. Hwang
    Glenn A. Stewart
    Thai H. Ho
    Cassandra N. Moore
    Parminder Singh
    Renee K. Sharpsten
    Brian A. Costello
    Alan H. Bryce
    Prostate Cancer and Prostatic Diseases, 2022, 25 : 479 - 483
  • [29] Notch signaling and Tp53/RB1 pathway in pulmonary neuroendocrine tumorigenesis
    Ito, Takaaki
    Matsuo, Akira
    Hassan, Wael Abdo
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (02) : 213 - 219
  • [30] Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors
    Merten, Larissa
    Agaimy, Abbas
    Moskalev, Evgeny A.
    Giedl, Johannes
    Kayser, Claudia
    Geddert, Helene
    Schaefer, Inga-Marie
    Cameron, Silke
    Werner, Martin
    Stroebel, Philip
    Hartmann, Arndt
    Haller, Florian
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 (06) : 718 - 726
12345